Focused ancillary sessions


Focused sessions for startups, growth and public companies, heathtech and digital health startups and those looking at the US.

 

Healthtech Startup CEO Forum 300x

Tuesday, 7 September 11.00-12.45 CET

Intimate forum for 25 executives of Nordic heathtech and digital health startups.

John Drakenberg Renander, CEO, Alex Therapeutics
Chris Cadman, Senior Associate, Potter Clarkson
Moderator: Marianne Larsson, Director, HealthTech Nordic

John Drakenberg Renander, CEO, Alex Therapeutics    Chris Cadman, Senior Associate, Potter Clarkson    Marianne Larsson, Director, HealthTech Nordic

Hosted by:

Potter Clarkson


Public CEO Forum

Tuesday, 7 September 14.00-15.45 CET

Intimate forum for 25 executives from publicly listed Nordic biotech companies.

Jesper Ottergren, Partner, Vinge
Jonathan Gertler, CEO, Back Bay Life Science Advisors
Rami Levin, CEO, Saniona
Moderator: Don DeBethizy, Director, Argenx

Jesper Ottergren, Partner, Vinge    Jonathan Gertler, CEO, Back Bay Life Science Advisors    Rami Levin, CEO, Saniona    Don DeBethizy, Director, Argenx

Co-hosted by:

Back Bay Life Science Advisors   Nasdaq   Vinge

 


US IPO Workshop

Wednesday, 8 September 13.00-14.15 CET

Expert led workshop on the why, when and how of a US listing or dual-listing.

Matt Gehl, Partner, Covington
Brandon Thompson, Special Counsel, Covington

Matt Gehl, Partner, Covington    Brandon Thompson, Special Counsel, Covington

Hosted by:

Covington

 


Growth CEO Forum

Wednesday, 8 September 15.00-16.45 CET

Intimate forum for 25 executives post-series A Nordic biotech companies.

Chris Jeffers, Partner, Mintz

Chris Jeffers, Partner, Mintz

Co-hosted by:

Nasdaq   Mintz

 

DOWNLOAD BROCHURE